These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 14648018)
1. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition. Sakoff JA; Howitt IJ; Ackland SP; McCluskey A Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018 [TBL] [Abstract][Full Text] [Related]
2. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells. Temmink OH; Hoogeland MF; Fukushima M; Peters GJ Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590 [TBL] [Abstract][Full Text] [Related]
3. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829 [TBL] [Abstract][Full Text] [Related]
4. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells. Matsui SI; Arredondo MA; Wrzosek C; Rustum YM Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989 [TBL] [Abstract][Full Text] [Related]
5. ICI D1694 and idoxuridine: a synergistic antitumor combination. Pressacco J; Hedley DW; Erlichman C Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097 [TBL] [Abstract][Full Text] [Related]
6. Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines. van der Wilt CL; Kuiper CM; Peters GJ Oncol Res; 1999; 11(8):383-91. PubMed ID: 10803742 [TBL] [Abstract][Full Text] [Related]
7. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition. Webley SD; Welsh SJ; Jackman AL; Aherne GW Br J Cancer; 2001 Aug; 85(3):446-52. PubMed ID: 11487279 [TBL] [Abstract][Full Text] [Related]
8. [Effects of nolatrexed on thymidylate synthase protein expression]. Li YL; Wu SG Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):881-4. PubMed ID: 15321751 [TBL] [Abstract][Full Text] [Related]
10. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity. Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869 [TBL] [Abstract][Full Text] [Related]
11. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells. Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972 [TBL] [Abstract][Full Text] [Related]
12. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929 [TBL] [Abstract][Full Text] [Related]
13. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues. Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183 [TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A. Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676 [TBL] [Abstract][Full Text] [Related]
15. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase. Berg RW; Werner M; Ferguson PJ; Postenka C; Vincent M; Koropatnick DJ; Behrend E J Pharmacol Exp Ther; 2001 Aug; 298(2):477-84. PubMed ID: 11454908 [TBL] [Abstract][Full Text] [Related]
16. Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331. Ford HE; Mitchell F; Cunningham D; Farrugia DC; Hill ME; Rees C; Calvert AH; Judson IR; Jackman AL Clin Cancer Res; 2002 Jan; 8(1):103-9. PubMed ID: 11801545 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU. Subbarayan PR; Lee K; Ardalan B Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422 [TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines. McGuire JJ; Magee KJ; Russell CA; Canestrari JM Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Curtin NJ; Harris AL; Aherne GW Cancer Res; 1991 May; 51(9):2346-52. PubMed ID: 2015598 [TBL] [Abstract][Full Text] [Related]
20. Cell death in response to antimetabolites directed at thymidylate synthase. Barbour KW; Berger FG Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]